12 March 2022: Lab/In Vitro Research
Downregulated Expression of RIPOR3 Correlated with Immune Infiltrates Predicts Poor Prognosis in Oral Tongue Cancer
Kai Zhang 1BCDE , Junlong Da 1F , Xiaoyao Liu 1F , Xinpeng Liu 1F , Jianqun Wang 1F , Han Jin 1D , Ying Li 1D , Bin Zhang 12AG*DOI: 10.12659/MSM.935055
Med Sci Monit 2022; 28:e935055
Figure 8 Immunohistochemical analysis of RIPOR3 protein expression in 20 major malignant tumors and expression levels in normal and oral squamous cell carcinoma of the mobile tongue (OTSCC) patients. (A) Changes of protein expression in different malignant tumors. (B) Difference in RIPOR3 expression between normal tongue tissues and OTSCC patients from GSE31056 dataset. (C) Negative RIPOR3 expression in normal tongue tissue. (D) Low protein expression in cancer tissues (stage II, T2). (E) Moderate RIPOR3 expression in normal tongue tissue. (F) Moderate RIPOR3 expression in OTSCC tissue (stage III,T3).